Role of new and established antiepileptic drugs.
Leppik
I E
IE
MINCEP Epilepsy Care, and Department of Neurology and Pharmacy, University of Minnesota, Minneapolis 55427, USA.
D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D004828:Epilepsies, Partial / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy*; D000078328:Felbamate; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D000077213:Lamotrigine; D009557:Nipecotic Acids / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D048448:Phenylcarbamates; D011409:Propylene Glycols / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D013723:Teratogens; D000078308:Tiagabine; D000077236:Topiramate; D014227:Triazines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use
D000927:Anticonvulsants; D009557:Nipecotic Acids; D048448:Phenylcarbamates; D011409:Propylene Glycols; D013723:Teratogens; D014227:Triazines; D000077236:Topiramate; D005632:Fructose; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin; D000077213:Lamotrigine; D000078328:Felbamate; D000078308:Tiagabine